A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Conditions

• Medulloblastoma
• Glioblastoma Multiforme
• Anaplastic Astrocytoma
• High-grade Astrocytoma NOS
• Anaplastic Oligodendroglioma
• Anaplastic Ependymoma
• Ependymoma
• Diffuse Intrinsic Pontine Glioma

Interventions

• BIOLOGICAL: SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
• BIOLOGICAL: SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years
• BIOLOGICAL: SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

Sponsor

Children's Oncology Group

Collaborators

• [object Object]
• [object Object]